epigallocatechin gallate has been researched along with Metabolic Syndrome in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 16 (76.19) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, J; Chen, F; Chen, J; Gan, W; Ren, K; Wang, M; Wang, T; Yu, P; Zhang, F; Zhang, Z | 1 |
| Fan, R; Ji, X; Liu, X; Liu, Z; Mi, Y; Qi, G | 1 |
| Chuang, SM; Ho, WT; Juan, YS; Lee, YC; Lee, YL; Lin, KL; Wu, BN; Wu, WJ | 1 |
| Hibi, M; Iwasaki, M; Katsuragi, Y; Osaki, N; Takase, H | 1 |
| Eisenstein, M | 1 |
| Kim, JJ; Qu, X; Sun, YL; Tan, Y; Xiao, L | 1 |
| Alcorta, P; Barrenechea, L; Labayen, I; Larrarte, E; Margareto, J; Mielgo-Ayuso, J | 1 |
| Bajerska, J; Mildner-Szkudlarz, S; Walkowiak, J | 1 |
| Clere, N; Faure, S; Fillon, L; Legeay, S; Rodier, M | 1 |
| Huang, J; Wang, Y; Yang, CS; Zhang, J; Zhang, L | 1 |
| Chen, J; Song, H | 1 |
| Bluck, L; Brown, AL; Coverly, J; Coward, A; Hendrickx, H; Jackson, S; Lane, J; Stephen, A; Stocks, J | 1 |
| Bose, M; Ju, J; Lambert, JD; Reuhl, KR; Shapses, SA; Yang, CS | 1 |
| Begg, DP; Bezzina, R; Cameron-Smith, D; Chen, N; Hinch, E; Jois, M; Lewandowski, PA; Mathai, ML; Sinclair, AJ; Wark, JD; Weisinger, HS; Weisinger, RS | 1 |
| Aston, CE; Basu, A; Betts, NM; Leyva, MJ; Lyons, TJ; Sanchez, K; Wu, M | 1 |
| Aston, CE; Basu, A; Betts, NM; Blevins, S; Du, M; Leyva, MJ; Lyons, TJ; Sanchez, K; Wu, M | 1 |
| Grove, KA; Lambert, JD; Sae-tan, S | 1 |
| Cherniack, EP | 1 |
| Grove, KA; Kennett, MJ; Lambert, JD; Sae-tan, S | 1 |
| Chen, YK; Cheung, C; Lee, MJ; Liu, AB; Lu, YP; Reuhl, KR; Yang, CS | 1 |
| Cheng, TO | 1 |
6 review(s) available for epigallocatechin gallate and Metabolic Syndrome
| Article | Year |
|---|---|
Efficacy of tea catechin-rich beverages to reduce abdominal adiposity and metabolic syndrome risks in obese and overweight subjects: a pooled analysis of 6 human trials.
Topics: Abdominal Fat; Adult; Camellia sinensis; Catechin; Female; Humans; Intra-Abdominal Fat; Male; Metabolic Syndrome; Middle Aged; Obesity; Overweight; Phytotherapy; Plant Extracts; Subcutaneous Fat; Tea; Treatment Outcome | 2018 |
Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome.
Topics: Biological Availability; Catechin; Humans; Metabolic Syndrome; Tea | 2015 |
Mechanisms of body weight reduction and metabolic syndrome alleviation by tea.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Liver; Meta-Analysis as Topic; Metabolic Syndrome; Muscle, Skeletal; Plant Leaves; Polyphenols; Randomized Controlled Trials as Topic; Risk Factors; Tea; Weight Loss | 2016 |
Weight control and prevention of metabolic syndrome by green tea.
Topics: Animals; Body Weight; Catechin; Flavonoids; Humans; Metabolic Syndrome; Phenols; Polyphenols; Tea | 2011 |
Polyphenols: planting the seeds of treatment for the metabolic syndrome.
Topics: Animals; Antioxidants; Catechin; Curcumin; Flavonoids; Humans; Metabolic Syndrome; Phenols; Plant Extracts; Polyphenols; Quercetin; Resveratrol; Stilbenes | 2011 |
All teas are not created equal: the Chinese green tea and cardiovascular health.
Topics: Animals; Antioxidants; Atherosclerosis; Cardiovascular Diseases; Cardiovascular System; Catechin; Diabetes Mellitus; Endothelium, Vascular; Humans; Metabolic Syndrome; Obesity; Phytotherapy; Plant Extracts; Tea | 2006 |
5 trial(s) available for epigallocatechin gallate and Metabolic Syndrome
| Article | Year |
|---|---|
Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial.
Topics: Adult; Anti-Obesity Agents; Antioxidants; Body Mass Index; Camellia sinensis; Catechin; Diet, Reducing; Dietary Supplements; Double-Blind Method; Energy Metabolism; Female; Humans; Insulin Resistance; Liver; Metabolic Syndrome; Middle Aged; Obesity; Plant Extracts; Plant Leaves; Risk Factors; Spain; Young Adult | 2014 |
Effects of rye bread enriched with green tea extract on weight maintenance and the characteristics of metabolic syndrome following weight loss: a pilot study.
Topics: Blood Pressure; Body Mass Index; Body Weight Maintenance; Bread; Caffeine; Camellia sinensis; Catechin; Diet, Reducing; Edible Grain; Energy Intake; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Phytotherapy; Plant Extracts; Secale; Single-Blind Method; Waist Circumference; Weight Loss | 2015 |
Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial.
Topics: Adult; Affect; Aged; Antihypertensive Agents; Catechin; Diastole; Dietary Supplements; Double-Blind Method; Glucose Tolerance Test; Humans; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Phytotherapy; Treatment Failure | 2009 |
Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome.
Topics: Adult; Aldehydes; Biological Availability; Body Mass Index; Body Weight; Camellia sinensis; Case-Control Studies; Catechin; Cholesterol; Female; Humans; Hypolipidemic Agents; Lipid Peroxidation; Male; Malondialdehyde; Metabolic Syndrome; Obesity; Patient Compliance; Phytotherapy; Plant Extracts; Single-Blind Method | 2010 |
Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome.
Topics: Adult; Antioxidants; Biomarkers; C-Reactive Protein; Camellia sinensis; Cardiovascular Diseases; Catechin; Female; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Obesity; Phytotherapy; Plant Extracts; Single-Blind Method; Tea; Vascular Cell Adhesion Molecule-1 | 2011 |
10 other study(ies) available for epigallocatechin gallate and Metabolic Syndrome
| Article | Year |
|---|---|
Beneficial effects of green tea on age related diseases.
Topics: Aging; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Functional Food; Humans; Metabolic Syndrome; Obesity; Plant Extracts; Tea | 2020 |
EGCG ameliorates diet-induced metabolic syndrome associating with the circadian clock.
Topics: Adipose Tissue, Brown; Adipose Tissue, White; Animals; Catechin; Circadian Clocks; Dietary Carbohydrates; Fructose; Liver; Metabolic Syndrome; Mice | 2017 |
Epigallocatechin-3-gallate alleviates bladder overactivity in a rat model with metabolic syndrome and ovarian hormone deficiency through mitochondria apoptosis pathways.
Topics: Animals; Apoptosis; Biomarkers; Catechin; Diet, Carbohydrate Loading; Diet, High-Fat; Disease Models, Animal; Female; Metabolic Syndrome; Mitochondria; Ovariectomy; Oxidative Stress; Plant Extracts; Primary Ovarian Insufficiency; Rats; Rats, Sprague-Dawley; Tea; Urinary Bladder, Overactive | 2018 |
Tea's value as a cancer therapy is steeped in uncertainty.
Topics: Animals; Biological Products; Case-Control Studies; Catechin; Cell Line, Tumor; China; Cohort Studies; Dietary Supplements; Disease Models, Animal; Female; Humans; Incidence; Japan; Life Style; Male; Metabolic Syndrome; Mice; Neoplasms; Plant Extracts; Prostatic Neoplasms; Sex Factors; Smoking; Sunitinib; Tea; Uncertainty | 2019 |
Green tea polyphenol epigallocatechin-3-gallate enhance glycogen synthesis and inhibit lipogenesis in hepatocytes.
Topics: Antioxidants; Catechin; Diabetes Mellitus, Type 2; Glycogen; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Lipogenesis; Metabolic Syndrome; Phosphorylation; Proto-Oncogene Proteins c-akt; Tea | 2013 |
Protective potential of epigallocatechin-3-gallate against benign prostatic hyperplasia in metabolic syndrome rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Catechin; Cytokines; Disease Models, Animal; Male; Metabolic Syndrome; Oxidative Stress; Peroxisome Proliferator-Activated Receptors; Prostatic Hyperplasia; Rats, Sprague-Dawley; Somatomedins | 2016 |
The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice.
Topics: Adipose Tissue; Animals; Biomarkers; Body Weight; Catechin; Diet; Dietary Fats; Eating; Fatty Liver; Feces; Lipids; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Tea | 2008 |
Green tea, black tea, and epigallocatechin modify body composition, improve glucose tolerance, and differentially alter metabolic gene expression in rats fed a high-fat diet.
Topics: Adipocytes; Adipose Tissue; Animals; Antioxidants; Biomarkers; Body Composition; Camellia sinensis; Catechin; Cell Differentiation; Diet, Atherogenic; Dietary Fats; Fatty Acids; Gene Expression; Gene Expression Regulation; Glucose Intolerance; Liver; Male; Metabolic Syndrome; Muscle, Skeletal; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tea; Thermogenesis | 2009 |
(-)-Epigallocatechin-3-gallate inhibits pancreatic lipase and reduces body weight gain in high fat-fed obese mice.
Topics: Animals; Antioxidants; Body Weight; Catechin; Diet, High-Fat; Feces; Lipase; Lipids; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity | 2012 |
Effects of green tea polyphenol (-)-epigallocatechin-3-gallate on newly developed high-fat/Western-style diet-induced obesity and metabolic syndrome in mice.
Topics: Animals; Blood Glucose; Body Weight; Catechin; Diet, High-Fat; Disease Models, Animal; Humans; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Plant Extracts; Polyphenols | 2011 |